HEXAMINOLEVULINATE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for hexaminolevulinate hydrochloride and what is the scope of freedom to operate?
Hexaminolevulinate hydrochloride
is the generic ingredient in one branded drug marketed by Photocure Asa and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Hexaminolevulinate hydrochloride has twenty-nine patent family members in seventeen countries.
One supplier is listed for this compound.
Summary for HEXAMINOLEVULINATE HYDROCHLORIDE
| International Patents: | 29 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 74 |
| Clinical Trials: | 11 |
| Patent Applications: | 246 |
| What excipients (inactive ingredients) are in HEXAMINOLEVULINATE HYDROCHLORIDE? | HEXAMINOLEVULINATE HYDROCHLORIDE excipients list |
| DailyMed Link: | HEXAMINOLEVULINATE HYDROCHLORIDE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for HEXAMINOLEVULINATE HYDROCHLORIDE
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for HEXAMINOLEVULINATE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| KARL STORZ Endoscopy-America, Inc. | Phase 2 |
| Dr. Te Vuong | Phase 2 |
| Photocure | Phase 2/Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for HEXAMINOLEVULINATE HYDROCHLORIDE
US Patents and Regulatory Information for HEXAMINOLEVULINATE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HEXAMINOLEVULINATE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ⤷ Sign Up | ⤷ Sign Up |
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ⤷ Sign Up | ⤷ Sign Up |
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ⤷ Sign Up | ⤷ Sign Up |
| Photocure Asa | CYSVIEW KIT | hexaminolevulinate hydrochloride | FOR SOLUTION;INTRAVESICAL | 022555-001 | May 28, 2010 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HEXAMINOLEVULINATE HYDROCHLORIDE
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| European Patent Office | 3389716 | PROCÉDÉ DE THÉRAPIE PHOTODYNAMIQUE (PDT) POUR LE CANCER DE LA VESSIE (METHOD OF PHOTODYNAMIC THERAPY (PDT) FOR BLADDER CANCER) | ⤷ Sign Up |
| Russian Federation | 2018124868 | НЕОАДЪЮВАНТНАЯ ТЕРАПИЯ ДЛЯ РАКА МОЧЕВОГО ПУЗЫРЯ | ⤷ Sign Up |
| Australia | 2016372575 | Method of photodynamic therapy (PDT) for bladder cancer | ⤷ Sign Up |
| Australia | 2016372573 | Neoadjuvant therapy for bladder cancer | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
